首页|期刊导航|疑难病杂志|血清Nrf2、MCPIP1、BRD4水平与心房颤动患者射频消融术后复发的相关性及预测意义

血清Nrf2、MCPIP1、BRD4水平与心房颤动患者射频消融术后复发的相关性及预测意义OA

Correlation and predictive significance of serum Nrf2,MCPIP1 and BRD4 expression with postoperative recurrence in atrial fibrillation patients undergoing radiofrequency ablation

中文摘要英文摘要

目的 探究心房颤动(AF)患者血清核因子E2相关因子2(Nrf2)、单核细胞趋化蛋白诱导蛋白1(MCPIP1)、溴结构域蛋白4(BRD4)水平与射频消融术(RFA)后复发的相关性及预测意义.方法 选取2023年7月—2024年7月北大荒集团总医院心血管二科收治的AF患者136例为AF组,根据RFA后复发情况分为复发亚组(n=52)与非复发亚组(n=84),另选取同期医院健康体检者136例为NC组.采用ELISA法检测血清Nrf2、MCPIP1、BRD4水平;多因素Logistic回归模型筛选影响AF患者RFA后复发的相关因素;基于受试者工作特征(ROC)曲线探究血清Nrf2、MCPIP1、BRD4水平对AF患者RFA后复发的预测价值;决策曲线分析(DCA)联合预测模型的临床实用价值.结果 与NC组比较,AF组患者血清Nrf2水平降低,血清MCPIP1、BRD4水平升高(t/P=8.026/<0.001、12.905/<0.001、12.889/<0.001);与非复发亚组比较,复发亚组心率快、左心房内径(LAD)大,血清Nrf2水平降低,血清 MCPIP1 与 BRD4 水平升高(t/P=6.075/<0.001、4.944/<0.001、6.596/<0.001、8.550/<0.001、7.507/<0.001);心率快、LAD 大、MCPIP1 高、BRD4 高是 AF 患者 RFA 后复发的危险因素[OR(95%CI)=1.083(1.023~1.145)、1.165(1.055~1.287)、4.746(1.765~12.763)、4.385(1.681~11.439)],Nrf2 高是保护因素[OR(95%CI)=0.036(0.005~0.250)];血清Nrf2、MCPIP1、BRD4水平及三者联合预测AF患者RFA后复发的AUC分别为0.813、0.820、0.819、0.921,且三者联合预测的AUC显著高于其各自单独预测(Z/P=2.560/0.010、2.300/0.021、2.323/0.020);在高风险阈值0.07~0.84范围内,血清Nrf2、MCPIP1、BRD4水平联合模型预测AF患者RFA后复发的净获益率高于单独预测.结论 AF患者血清Nrf2水平下调,血清MCPIP1、BRD4水平上调,与患者RFA后复发紧密相关,且能够作为预测AF患者术后复发的生物标志物.

Objective To explore the correlation and predictive significance of serum nuclear factor E2-related factor 2(Nrf2),monocyte chemoattractant protein-induced protein 1(MCPIP1),and bromodomain-containing protein 4(BRD4)ex-pression with postoperative recurrence in patients with atrial fibrillation(AF)undergoing radiofrequency ablation(RFA).Methods From July 2023 to July 2024,136 patients with atrial fibrillation(AF)admitted to the Second Department of Car-diovascular Medicine,Beidahuang Group General Hospital were selected as the AF group.According to the recurrence status after radiofrequency ablation(RFA),they were further divided into a recurrence subgroup(n=52)and a non-recurrence sub-group(n=84).Meanwhile,136 healthy individuals who underwent physical examinations at the same hospital during the same period were enrolled as the normal control(NC)group.ELISA method was implemented to detect serum Nrf2,MCPIP1,and BRD4 levels.Multi-factor Logical regression analysis was applied to identify factors related to post-RFA recurrence in AF pa-tients.ROC curve analysis was used to explore the predictive value of serum Nrf2,MCPIP1 and BRD4.DCA was performed to assess the clinical utility of the combined model.Results Compared with the NC group,the AF group had a lower serum Nrf2 level and higher serum MCPIP1 and BRD4 levels(t/P=8.026/<0.001,t/P=12.905/<0.001,t/P=12.889/<0.001).Com-pared with the non-recurrence subgroup,the recurrence subgroup showed a decreased serum Nrf2 level,as well as increased left atrial diameter(LAD),heart rate,and serum levels of MCPIP1 and BRD4(t/P=6.596/<0.001,t/P=6.705<0.001,t/P=4.944<0.001,t/P=8.550<0.001,t/P=7.507<0.001).Multivariate analysis revealed that larger LAD,faster heart rate,and higher serum levels of MCPIP1 and BRD4 were risk factors for post-RFA recurrence in AF patients,while higher serum Nrf2 level was a protective factor[odds ratio(95%confidence interval)=1.165(1.055-1.287),1.083(1.023-1.145),4.746(1.765-12.763),4.385(1.681-11.439),0.036(0.005-0.250)].The area under the receiver operating characteristic curve(AUC)of se-rum Nrf2,MCPIP1,BRD4 alone,and their combination for predicting post-RFA recurrence in AF patients was 0.813,0.820,0.819,and 0.921,respectively.Notably,the combined AUC was significantly higher than that of each single indicator(Z/P=2.560/0.010,Z/P=2.300/0.021,Z/P=2.323/0.020).Within the high-risk threshold range of 0.07~0.84,the combined model of serum Nrf2,MCPIP1,and BRD4 levels had a higher net benefit rate in predicting recurrence in AF patients after post-RFA re-currence than their individual predictions.Conclusion In AF patients,serum Nrf2 level is are downregulated,while serum MCPIP1 and BRD4 levels are upregulated.They are closely related to recurrence post-RFA recurrence and can serve as bio-markers for predicting postoperative recurrence in AF patients.

张佰爽;谭春淼;高一飞;李彩莹

150088 哈尔滨,北大荒集团总医院心血管二科150088 哈尔滨,北大荒集团总医院心血管二科150088 哈尔滨,北大荒集团总医院心血管二科150088 哈尔滨,北大荒集团总医院心血管二科

医药卫生

心房颤动射频消融术复发核因子E2相关因子2单核细胞趋化蛋白诱导蛋白1溴结构域蛋白4

Atrial fibrillationRadiofrequency ablationPostoperative recurrenceNuclear factor E2-related factor 2Monocyte chemoattractant protein-induced protein 1Bromine domain protein 4

《疑难病杂志》 2026 (5)

541-546,6

黑龙江省卫生健康委科研课题项目(2023-262) Research Project of the Health Commission of Heilongjiang Province(2023-262)

10.3969/j.issn.1671-6450.2026.05.006

评论